In support of initial observations, anchor-independent growth was severely hampered after treating glioma CSCs with PI3K inhibitors, showing reduced WIP and nestin in clear correlation with low levels of Akt activity [33,45]. This evidence concerns the gene AKT1 and central nervous system cancer.